-
Je něco špatně v tomto záznamu ?
Antimicrobial nanofibrous mats with controllable drug release produced from hydrophobized hyaluronan
L. Bardoňová, A. Kotzianová, K. Skuhrovcová, O. Židek, T. Bártová, J. Kulhánek, T. Hanová, K. Mamulová Kutláková, H. Vágnerová, V. Krpatová, M. Knor, J. Starigazdová, P. Holomková, R. Buffa, V. Velebný
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články
- MeSH
- antibakteriální látky chemie farmakologie toxicita MeSH
- buňky 3T3 MeSH
- hydrofobní a hydrofilní interakce MeSH
- iminy chemie farmakologie toxicita MeSH
- kyselina hyaluronová chemie farmakologie toxicita MeSH
- léky s prodlouženým účinkem chemie farmakologie toxicita MeSH
- mikrobiální testy citlivosti MeSH
- myši MeSH
- nanovlákna chemie toxicita MeSH
- nosiče léků chemie farmakologie toxicita MeSH
- Pseudomonas aeruginosa účinky léků MeSH
- pyridiny chemie farmakologie toxicita MeSH
- Staphylococcus aureus účinky léků MeSH
- triclosan chemie farmakologie toxicita MeSH
- uvolňování léčiv MeSH
- zvířata MeSH
- Check Tag
- myši MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
Due to their large active surface, high loading efficiency, and tunable dissolution profiles, nanofibrous mats are often cited as promising drug carriers or antimicrobial membranes. Hyaluronic acid has outstanding biocompatibility, but it is hydrophilic. Nanofibrous structures made from hyaluronan dissolve immediately, making them unsuitable for controlled drug release and longer applications. We aimed to prepare a hyaluronan-based antimicrobial nanofibrous material, which would retain its integrity in aqueous environments. Self-supporting nanofibrous mats containing octenidine dihydrochloride or triclosan were produced by electrospinning from hydrophobized hyaluronan modified with a symmetric lauric acid anhydride. The nanofibrous mats required no cross-linking to be stable in PBS for 7 days. The encapsulation efficiency of antiseptics was nearly 100%. Minimal release of octenidine was observed, while up to 30% of triclosan was gradually released in 72 h. The nanofibrous materials exhibited antimicrobial activity, the fibroblast viability was directly dependent on the antiseptic content and its release.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22003791
- 003
- CZ-PrNML
- 005
- 20250318144509.0
- 007
- ta
- 008
- 220113e20210519xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.carbpol.2021.118225 $2 doi
- 035 __
- $a (PubMed)34119178
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Bardoňová, Lenka $u CONTIPRO a.s., Dolní Dobrouč 401, 561 02, Czech Republic; Nanotechnology Centre, Energy and Environmental Technology Centre, VŠB - Technical University of Ostrava, 17. listopadu 2172/15, 708 00 Ostrava, Czech Republic. Electronic address: bardonova@contipro.com
- 245 10
- $a Antimicrobial nanofibrous mats with controllable drug release produced from hydrophobized hyaluronan / $c L. Bardoňová, A. Kotzianová, K. Skuhrovcová, O. Židek, T. Bártová, J. Kulhánek, T. Hanová, K. Mamulová Kutláková, H. Vágnerová, V. Krpatová, M. Knor, J. Starigazdová, P. Holomková, R. Buffa, V. Velebný
- 520 9_
- $a Due to their large active surface, high loading efficiency, and tunable dissolution profiles, nanofibrous mats are often cited as promising drug carriers or antimicrobial membranes. Hyaluronic acid has outstanding biocompatibility, but it is hydrophilic. Nanofibrous structures made from hyaluronan dissolve immediately, making them unsuitable for controlled drug release and longer applications. We aimed to prepare a hyaluronan-based antimicrobial nanofibrous material, which would retain its integrity in aqueous environments. Self-supporting nanofibrous mats containing octenidine dihydrochloride or triclosan were produced by electrospinning from hydrophobized hyaluronan modified with a symmetric lauric acid anhydride. The nanofibrous mats required no cross-linking to be stable in PBS for 7 days. The encapsulation efficiency of antiseptics was nearly 100%. Minimal release of octenidine was observed, while up to 30% of triclosan was gradually released in 72 h. The nanofibrous materials exhibited antimicrobial activity, the fibroblast viability was directly dependent on the antiseptic content and its release.
- 650 _2
- $a buňky 3T3 $7 D016475
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a antibakteriální látky $x chemie $x farmakologie $x toxicita $7 D000900
- 650 _2
- $a léky s prodlouženým účinkem $x chemie $x farmakologie $x toxicita $7 D003692
- 650 _2
- $a nosiče léků $x chemie $x farmakologie $x toxicita $7 D004337
- 650 _2
- $a uvolňování léčiv $7 D065546
- 650 _2
- $a kyselina hyaluronová $x chemie $x farmakologie $x toxicita $7 D006820
- 650 _2
- $a hydrofobní a hydrofilní interakce $7 D057927
- 650 _2
- $a iminy $x chemie $x farmakologie $x toxicita $7 D007097
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a mikrobiální testy citlivosti $7 D008826
- 650 _2
- $a nanovlákna $x chemie $x toxicita $7 D057139
- 650 _2
- $a Pseudomonas aeruginosa $x účinky léků $7 D011550
- 650 _2
- $a pyridiny $x chemie $x farmakologie $x toxicita $7 D011725
- 650 _2
- $a Staphylococcus aureus $x účinky léků $7 D013211
- 650 _2
- $a triclosan $x chemie $x farmakologie $x toxicita $7 D014260
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Kotzianová, Adéla $u CONTIPRO a.s., Dolní Dobrouč 401, 561 02, Czech Republic. Electronic address: kotzianova@contipro.com
- 700 1_
- $a Skuhrovcová, Kristýna $u CONTIPRO a.s., Dolní Dobrouč 401, 561 02, Czech Republic. Electronic address: skuhrovcova@contipro.com
- 700 1_
- $a Židek, Ondřej $u CONTIPRO a.s., Dolní Dobrouč 401, 561 02, Czech Republic. Electronic address: zidek@contipro.com
- 700 1_
- $a Bártová, Tereza $u CONTIPRO a.s., Dolní Dobrouč 401, 561 02, Czech Republic. Electronic address: bartova@contipro.com
- 700 1_
- $a Kulhánek, Jaromír $u CONTIPRO a.s., Dolní Dobrouč 401, 561 02, Czech Republic. Electronic address: kulhanek@contipro.com
- 700 1_
- $a Hanová, Tereza $u CONTIPRO a.s., Dolní Dobrouč 401, 561 02, Czech Republic. Electronic address: hanova@contipro.com
- 700 1_
- $a Mamulová Kutláková, Kateřina $u Nanotechnology Centre, Energy and Environmental Technology Centre, VŠB - Technical University of Ostrava, 17. listopadu 2172/15, 708 00 Ostrava, Czech Republic. Electronic address: katerina.mamulova.kutlakova@vsb.cz
- 700 1_
- $a Vágnerová, Hana $u CONTIPRO a.s., Dolní Dobrouč 401, 561 02, Czech Republic. Electronic address: vagnerova@contipro.com
- 700 1_
- $a Krpatová, Věra $u CONTIPRO a.s., Dolní Dobrouč 401, 561 02, Czech Republic. Electronic address: krpatova@contipro.com
- 700 1_
- $a Knor, Michal $u CONTIPRO a.s., Dolní Dobrouč 401, 561 02, Czech Republic. Electronic address: michal.knor@seznam.cz
- 700 1_
- $a Starigazdová, Jana $u CONTIPRO a.s., Dolní Dobrouč 401, 561 02, Czech Republic. Electronic address: starigazdova@contipro.com
- 700 1_
- $a Holomková, Pavlína $u CONTIPRO a.s., Dolní Dobrouč 401, 561 02, Czech Republic. Electronic address: holomkova@contipro.com
- 700 1_
- $a Buffa, Radovan $u CONTIPRO a.s., Dolní Dobrouč 401, 561 02, Czech Republic. Electronic address: buffa@contipro.com $7 xx0330178
- 700 1_
- $a Velebný, Vladimír $u CONTIPRO a.s., Dolní Dobrouč 401, 561 02, Czech Republic. Electronic address: velebny@contipro.com
- 773 0_
- $w MED00006149 $t Carbohydrate polymers $x 1879-1344 $g Roč. 267 (20210519), s. 118225
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34119178 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220113 $b ABA008
- 991 __
- $a 20250318144506 $b ABA008
- 999 __
- $a ok $b bmc $g 1751296 $s 1154940
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 267 $c - $d 118225 $e 20210519 $i 1879-1344 $m Carbohydrate polymers $n Carbohydr Polym $x MED00006149
- LZP __
- $a Pubmed-20220113